Skip to main content

Table 5 Input variables and cost estimates for inappropriate manoeuvres (1999 dollars)

From: Cost savings associated with improving appropriate and reducing inappropriate preventive care: cost-consequences analysis

Variable

Value and Rangea

Source

D Manoeuvres

  

Blood Glucose Screening

  

Difference in eligible patients not screened

4709 (2329,7089)

(36)

Specificity of blood glucose test

89%

(3)

Cost of fasting glucose test

$10.34

(57)

Cost of glucose tolerance test

$23.26

(57)

Cost of HgA1c

$19.12

(57)

PSA Testing

  

Difference in eligible patients not screened

95 (-932, 1122)

(36)

Cost of PSA Test

$25

(57)

Specificity of PSA test

40%

(3)

Cost of Biopsy*

$232.83

(58)

Mammography 40 to 49

  

Difference in eligible patients not screened

295 (-296, 887)

(36)

Cost of mammogram

$76.54

(57)

Incidence of breast cancer

.001616

(42)

Specificity of mammogram

96.5%

(3)

Cost of Biopsy

$2,164

(42)

Chest X-Ray

  

Difference in eligible patients not screened

276 (-271, 822)

(36)

Cost of chest x-ray

$233

(40)

Urine Proteinuria Screening

  

Difference in eligible patients not screened

9947 (7934,11961)

(36)

Specificity of urine dipstick test

95%

(3)

Cost of Urine culture and urinalysis

$27.18

(57)

  1. a 95% Confidence Intervals
  2. *Includes intracavitary ultrasonography, ultrasound guidance of biopsy and needle biopsy of the prostate